Streetbeat News

Price Targets

SUI

Compass Point analyst Merrill Ross has maintained a Neutral rating on Sun Communities (NYSE:SUI) and lowered the price target from $125 to $116.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 3:42 pm

SHYF

Craig-Hallum analyst Steve Dyer maintains a 'Hold' rating on Shyft Group (NASDAQ:SHYF) and lowers the price target from $16 to $12.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 3:39 pm

TCBX

Stephens & Co. analyst Matt Olney maintains an Overweight rating on Third Coast Bancshares (NASDAQ:TCBX) but lowers the price target from $23 to $20.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 3:39 pm

INBK

Craig-Hallum analyst George Sutton has maintained a 'Hold' rating on First Internet (NASDAQ:INBK) and lowered the price target from $22 to $19.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 3:38 pm

OSTK

DA Davidson analyst Tom Forte maintains a 'Buy' rating on Overstock.com (NASDAQ:OSTK) but lowers the price target from $85 to $41.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 3:37 pm

LSTR

Stephens & Co. analyst Jack Atkins has maintained an Equal-Weight rating on Landstar System (NASDAQ:LSTR) and lowered the price target from $210 to $190.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 3:36 pm

TER

Craig-Hallum analyst Christian Schwab maintains a 'Buy' rating on Teradyne (NASDAQ:TER) but lowers the price target from $131 to $115.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 3:35 pm

ATGE

Adtalem Global Education reported better-than-expected Q1 financial results and issued FY24 guidance. Baird upgraded the stock from Neutral to Outperform and raised its price target from $47 to $55.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 3:34 pm

CTS

Stephens & Co. analyst Justin Long maintains an Equal-Weight rating on CTS (NYSE:CTS) and lowers the price target from $41 to $39.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 3:33 pm

WST

Stephens & Co. analyst Jacob Johnson has maintained an Overweight rating on West Pharmaceutical Servs (NYSE:WST) but lowered the price target from $420 to $390.

Portfolio Pulse from Benzinga Newsdesk

October 27, 2023 | 3:32 pm